Bernard Munos of the Innothink Center for Research in Biomedical Innovation, provided the data.
Here are the drugmakers that have launched the most drugs in the last decade:
1. Novartis (17)
2. GlaxoSmithKline (14)
3. Johnson & Johnson (14)
4. Pfizer (13)
5. AstraZeneca (12)
6. Hoffmann- La Roche (12)
7. Merck & Co. (12)
8. Eli Lilly (9)
9. Sanofi (9)
10. Boehringer Ingelheim (7)
11. Bristol-Myers Squibb (7)
12. Bayer (6)
13. AbbVie (4)
Access the full report here.
More articles on pharmacy:
FDA approves AbbVie’s $59K rheumatoid arthritis drug
Teva launches generic version of EpiPen for kids
American Regent boosted price of essential hospital product by 1,300%
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
